Literature DB >> 26891415

Biochemical analysis of the living human vitreous.

Jan Kokavec1, San H Min2, Mei H Tan2, Jagjit S Gilhotra2, Henry S Newland2, Shane R Durkin2, John Grigg3, Robert J Casson2.   

Abstract

BACKGROUND: To date, our understanding of the biochemical composition of the living human vitreous relies on extrapolations from animal or human post-mortem studies.
METHODS: This was a cross-sectional study of vitreous samples from 27 individuals scheduled for retinal surgery within a tertiary hospital. From each vitreous sample, the concentrations of sodium, potassium, chloride, calcium, magnesium, glucose, lactate, β- hydroxybutyrate, copper, zinc, selenium, iron, ferritin and transferrin and osmolality were measured. Perioperative serum samples were also obtained for comparison.
RESULTS: The following vitreous mean ± standard deviation (95% confidence interval of the mean) was observed for each analyte: sodium, 146.7 ± 3.3 (145.4-148.0) mmol/L; potassium, 5.73 ± 0.86 (5.39-6.08) mmol/L; chloride, 121.6 ± 2.6 (120.6-122.7) mmol/L; calcium, 1.128 ± 0.518 (0.923-1.333) mmol/L; magnesium, 0.900 ± 0.158 (0.838-0.962) mmol/L; glucose, 2.97 ± 0.98 (2.58-3.36) mmol/L; lactate, 3.97 ± 1.09 (3.54-4.40) mmol/L; osmolality, 289.5 ± 6.9 (286.6-292.5) mOsm/kg; BOHB, 0.0937 ± 0.0472 (0.0750-0.1124) mmol/L; copper, 0.519 ± 0.269 (0.412-0.625) µmol/L; zinc, 1.95 ± 1.09 (1.52-2.38) µmol/L; selenium, 0.1035 ± 0.0276 (0.0923-0.1146) µmol/L; iron, 3.11 ± 1.40 (2.56-3.66) µmol/L; ferritin, 19.5 ± 10.3 (15.5-23.6) µg/L; transferrin, 0.0878 ± 0.0526 (0.0670-0.1086) g/L. Vitreous biochemistry was not significantly different between male and female participants. Vitreous biochemistry was significantly different between non-diabetic and diabetic participants. Vitreous biochemistry was significantly different from the vitreous substitute BSS Plus (Alcon, USA). The vitreous extracted from living humans was markedly different from the commonly reported reference values obtained from animal studies.
CONCLUSIONS: The current data provide hitherto unavailable information about the biochemical composition of the living human vitreous.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  ante-mortem; concentration; human; reference; vitreous

Mesh:

Substances:

Year:  2016        PMID: 26891415     DOI: 10.1111/ceo.12732

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  15 in total

1.  Protective effect of vitreous against hemoglobin neurotoxicity.

Authors:  Jing Chen-Roetling; Kathleen A Regan; Raymond F Regan
Journal:  Biochem Biophys Res Commun       Date:  2018-06-06       Impact factor: 3.575

2.  Evaluation of Sodium (23Na) MR-imaging as a Biomarker and Predictor for Neurodegenerative Changes in Patients With Alzheimer's Disease.

Authors:  Sherif A Mohamed; Katrin Herrmann; Anne Adlung; Nadia Paschke; Lucrezia Hausner; Lutz FrÖlich; Lothar Schad; Christoph Groden; Hans Ulrich Kerl
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 3.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

4.  The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery.

Authors:  Shrirang V Ranade; Mark R Wieland; Tammy Tam; Jennifer C Rea; Judit Horvath; Aaron R Hieb; Weitao Jia; Lori Grace; Giulio Barteselli; Jay M Stewart
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  Confirmation of Luteinizing Hormone (LH) in Living Human Vitreous and the Effect of LH Receptor Reduction on Murine Electroretinogram.

Authors:  Tammy Z Movsas; Kwoon Y Wong; Michael D Ober; Robert Sigler; Zhenmin M Lei; Arivalagan Muthusamy
Journal:  Neuroscience       Date:  2018-06-08       Impact factor: 3.590

6.  Epiretinal Membrane: Prevalence and Risk Factors from the Korea National Health and Nutrition Examination Survey, 2008 through 2012.

Authors:  Jong Min Kim; Hoyoung Lee; Jae Pil Shin; Jeeyun Ahn; Je Moon Yoo; Su Jeong Song; Sang Jin Kim; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2017-08-26

7.  Risk Factors for Fatal Hyperglycaemia Confirmed by Forensic Postmortem Examination - A Nationwide Cohort in Sweden.

Authors:  Lotta Walz; Anna K Jönsson; Brita Zilg; Carl Johan Östgren; Henrik Druid
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

8.  Using MALDI-TOF-MS to test Staphylococcus aureus-infected vitreous.

Authors:  Zhenyu Song; Xiuping Liu; Minyu Zhu; Yiwei Tan; Kaili Wu
Journal:  Mol Vis       Date:  2017-07-07       Impact factor: 2.367

9.  pH of anti-VEGF agents in the human vitreous: low impact of very different formulations.

Authors:  Bianka Sobolewska; Peter Heiduschka; Karl-Ulrich Bartz-Schmidt; Focke Ziemssen
Journal:  Int J Retina Vitreous       Date:  2017-06-26

10.  Comparisons of Vitreal Angiogenic, Inflammatory, Profibrotic Cytokines, and Chemokines Profile between Patients with Epiretinal Membrane and Macular Hole.

Authors:  Lu Chen; Weiwei Zhang; Ping Xie; Jiangdong Ji; Huiming Qian; Songtao Yuan; Qinghuai Liu; Zizhong Hu
Journal:  J Ophthalmol       Date:  2021-07-13       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.